• Welcome to Global Gulag Media Forum. Please login or sign up.
 

COVID-1984

Started by tahoeblue, Jan 11, 2020, 01:51:09 PM

Previous topic - Next topic

0 Members and 2 Guests are viewing this topic.

Dr. Naomi Hunter

https://twitter.com/WinterAsh12/status/1427627023212576769?s=20

What a "coincidence" that AU has been disarmed for a long time now after that false flag TPTB carried out that resulted in their disarmament huh?

#1 Trouble Maker

Quote from: Dr. Naomi Hunter on Aug 18, 2021, 08:36:12 PMhttps://twitter.com/WinterAsh12/status/1427627023212576769?s=20

What a "coincidence" that AU has been disarmed for a long time now after that false flag TPTB carried out that resulted in their disarmament huh?

How many cops does it take to harass kids for the crime of breathing fresh air?  Cops down under have completely lost their minds.
WE WILL NOT ACCEPT GENOCIDE AS THE NEW NORMAL EVER!!!

tahoeblue

https://stateofthenation.co/?p=51704
OPERATION COVID-19 & the 10 Stages of Genocide
Posted on February 8, 2021
by State of the Nation

The COVID Cult and the 10 Stages of Genocide
By Makia Freeman

    THE STORY: The COVID cult has dangerous implications when compared to previous governmental operations in history, including those that ended in genocide.
    THE IMPLICATIONS: Will the COVID cult culminate in deportation, persecution, imprisonment and even extermination of non-believers and dissenters?

...

The Planned SPARS Pandemic and the Limits of Tyrants

Before we get into the 10 stages, we all need to realize that the COVID scamdemic isn't going anywhere. It's only going to get worse until enough people stand up and challenge it. If the masses continue to act as acquiescent zombies, this fake pandemic may be pushed all the way until 2025, and will probably be 'augmented' with a false flag bio terror attack or a "Pandemic II" as NWO frontman Bill Gates predicted. Diana Lenska exposed another simulation called the The SPARS Pandemic which details a scenario where a new virus infects humanity in 2025, and lasts until 2028. We all how know how these 'simulations' have a strange and disturbing habit of becoming real ... just a coincidence, of course. At this juncture, it is worthwhile remembering this very important quote from Douglass Frederick:

    "The limits of tyrants are prescribed by the endurance of those whom they oppress."

...

| - - - -

https://www.israelnationalnews.com/News/News.aspx/293417
COVID vaccine is kosher, manufacturers promise
No pork used in coronavirus vaccines produced by Pfizer, Moderna, AstraZeneca.
Dec 20 , 2020 9:03 PM
...

However, Rabbi David Stav of the Tzohar rabbinical organization told AP that such an assurance was actually unnecessary, since an injected product (as opposed to one ingested via the mouth) did not have to be kosher according to the Torah's laws. "According to Jewish law, the prohibition on consuming pork or using it only applies when the pork is used in the 'normal manner,'" he said. "If the substance is injected rather than eaten, there is no prohibition and thus no issue, and this is especially the case when we are concerned about preventing disease."
...

Many vaccines for other diseases use or once used pork gelatin as a stabilizer, and several companies have switched to other, non-pork stabilizers in order to reassure kosher and Halal consumers.

Among the companies to have made such an announcement regarding their coronavirus products are Pfizer, AstraZeneca, and Moderna, all of which have contracts to supply the Israeli government with vaccines, according to the Associated Press. The Chinese pharmaceutical companies SinoPharm and Sinovac did not respond to AP's inquiry on the matter.
...

| - - - -

https://www.jpost.com/Israel-News/Culture/Kosher-True-Blood-489449
Kosher True Blood
Jewish vampire series turns tables on ancient blood libel.
By AMY SPIRO  MAY 1, 2017

Why has there never been a Jewish vampire?  ....

| - - -

https://www.ajc.com/pulse/tainted-blood-covid-skeptics-request-blood-transfusions-from-unvaccinated-donors/LANAPRVZPVEVXLBQXAYOV22WT4/

'Tainted' blood: COVID skeptics request blood transfusions from unvaccinated donors


With nearly 60% of the eligible U.S. population fully vaccinated, most of the nation's blood supply is now coming from donors who have been inoculated, experts said. That's led some patients who are skeptical of the shots to demand transfusions only from the unvaccinated, an option blood centers insist is neither medically sound nor operationally feasible.

...

So far, such demands have been rare, industry officials said. Dr. Louis Katz, chief medical officer for ImpactLife, an Iowa-based blood center, said he's heard from "a small handful" of patients asking for blood from unvaccinated donors. And the resounding answer from centers and hospitals, he added, has been "no."
...
In practical terms, blood centers have only limited access to donated blood that has not in some way been affected by COVID-19. Based on samples, Katz estimated that as much as 60% to 70% of the blood currently being donated is coming from vaccinated donors. Overall, more than 90% of current donors have either been infected with COVID-19 or vaccinated against it, said Dr. Michael Busch, director of the Vitalant Research Institute, who is monitoring antibody levels in samples from the U.S. blood supply.

"Less than 10% of the blood we collect does not have antibodies," Busch noted.

{ so 90 percent of the public has been exposed to covid ... }


https://www.heritagefl.com/story/2021/08/20/news/jewish-philanthropists-establish-ou-katz-family-initiative-to-support-jewish-identity-programs-for-public-school-teens/15378.html
Jewish philanthropists establish OU 'Katz Family Initiative' to support Jewish identity programs for public school teens
August 20, 2021

NEW YORK — Avi and Becky Katz, long-time Jewish communal leaders, have established a multi-year, multi-million national initiative with NCSY,the flagship youth movement of the Orthodox Union, to support Jewish identity programs for public school teenagers. Their $3 million dollar gift will focus on the OU's national Jewish Student Union program and will be called the Katz Family Initiative Driving Impact in JSU.

| - - -

https://www.baltimorehebrew.org/about/senior-staff-bios/
Rabbi Andrew Busch

Rabbi Andrew Busch joined Baltimore Hebrew Congregation in 2008. His many areas of focus include prayer, counseling, life cycle events, education and more. Rabbi Busch received a B.A. from Brandeis University and studied at Hebrew University in Jerusalem. He was ordained at the Hebrew Union College.

Before arriving at BHC, Rabbi Busch served as Rabbi at Touro Synagogue in New Orleans.
...

| - - -

https://research.vitalant.org/About-Us.aspx

Grantors
National Institutes of Health (NIH); US Food and Drug Administration (FDA); US Army Medical Research and Materiel Command (USAMRMC); Blood Systems

Industry Collaborations
Cerus; Roche; Grifols; Ortho-Clinical Diagnostics, Inc.; Gen-Probe, Inc.; Abbott Laboratories; TerumoBCT; Immunetics; Integral Molecular

Facilities
The Research Institute is housed within Blood Centers of the Pacific in San Francisco, CA. Our Research Institute has state-of-the-art equipment to support research related to blood and blood product safety in the areas of molecular biology, immunology, virology, tissue culture, cell processing and epidemiology. Staff have 9000 sq. ft. of labs (including a biosafety level 3 lab), and a 2200 sq. ft. freezer room with capacity to store more than one million specimens.


https://www.sciencemag.org/news/2020/04/unprecedented-nationwide-blood-studies-seek-track-us-coronavirus-spread

/....

Q: Shortly after transmission occurs and people are acutely infected, you're not going to have antibodies, are you?

A: The proportion of people who have recently acquired SARS-CoV-2 who would be positive with a single time point with nasal pharyngeal swab—the usual diagnostic sample, which uses the polymerase chain reaction to amplify tiny bits of viral nucleic acid so it can be detected—is probably 50%, or at best 70% to 80%. Antibody testing wouldn't pick people up in the earliest stages of infection who had asymptomatic infections, but the data are becoming very solid that within 4 to 5 days of earliest disease onset, antibodies are detectable. So if you really want to pick up acute infections, you need to add serology to nucleic acid testing.

Q: What serosurveys are you doing in the United States?

A: We're developing three large serosurvey studies. We need to do them at regular intervals to detect ongoing incidence, to determine if antibody responses are waning, and to assess herd immunity.

The first one, which will be funded by the National Institutes of Health, is already underway in six metropolitan regions in the U.S. It was started in Seattle when that outbreak happened, then New York City, then we quickly kicked in the San Francisco Bay area, and now we've added Los Angeles, Boston, and Minneapolis. Colleagues at regional blood centers are each saving 1000 samples from donors each month—often it's just a few days each month—and they're demographically defined so we know the age, the gender, and, most important, the zip code of the donor's residence. Those 6000 samples, collected each month starting in March and for the next 5 months, will be assessed with an antibody testing algorithm, which we're still finalizing, that will help us monitor how many people develop SARS-CoV-2 antibodies over time. That will show us when we're going from, say, a half a percent to 2% of the donors having antibodies.

tahoeblue

https://www.youtube.com/watch?v=GWPIhgknRhI
Covid Cover-Up: New BOMBSHELL Lab Leak Report!!
1,587,300 views

Aug 15, 2021
 Russell Brand

3.62M subscribers

Dr. Naomi Hunter



tahoeblue

https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/covid-19-vaccines
COVID-19 Vaccines Authorized for Emergency Use or FDA-Approved

    Comirnaty and Pfizer-BioNTech COVID-19 Vaccine
    Moderna COVID-19 Vaccine
    Janssen COVID-19 Vaccine

Fact sheets for health care providers and patients included
Report vaccine side effects toll-free at 1-800-822-7967 or online


https://www.fda.gov/news-events/press-announcements/fda-approves-first-covid-19-vaccine
FDA Approves First COVID-19 Vaccine
Approval Signifies Key Achievement for Public Health
August 23, 2021

Today, the U.S. Food and Drug Administration approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (koe-mir'-na-tee), for the prevention of COVID-19 disease in individuals 16 years of age and older. The vaccine also continues to be available under emergency use authorization (EUA), including for individuals 12 through 15 years of age and for the administration of a third dose in certain immunocompromised individuals.

...
Comirnaty contains messenger RNA (mRNA), a kind of genetic material. The mRNA is used by the body to make a mimic of one of the proteins in the virus that causes COVID-19.
...
Based on results from the clinical trial, the vaccine was 91% effective in preventing COVID-19 disease.

More than half of the clinical trial participants were followed for safety outcomes for at least four months after the second dose. Overall, approximately 12,000 recipients have been followed for at least 6 months.

The most commonly reported side effects by those clinical trial participants who received Comirnaty were pain, redness and swelling at the injection site, fatigue, headache, muscle or joint pain, chills, and fever. The vaccine is effective in preventing COVID-19 and potentially serious outcomes including hospitalization and death.

Additionally, the FDA conducted a rigorous evaluation of the post-authorization safety surveillance data pertaining to myocarditis and pericarditis following administration of the Pfizer-BioNTech COVID-19 Vaccine and has determined that the data demonstrate increased risks, particularly within the seven days following the second dose. The observed risk is higher among males under 40 years of age compared to females and older males. The observed risk is highest in males 12 through 17 years of age. Available data from short-term follow-up suggest that most individuals have had resolution of symptoms. However, some individuals required intensive care support.

Information is not yet available about potential long-term health outcomes.

The Comirnaty Prescribing Information includes a warning about these risks.

| - - - -

08/18/2021

Joint Statement from HHS Public Health and Medical Experts on COVID-19 Booster Shots

Public health and medical experts from the U.S. Department of Health and Human Services released a statement on the Administration's plan for COVID-19 booster shots for the American people.


| - - -

https://factcheckedorg.files.wordpress.com/2021/02/covid-vaccines.r5.1.pdf
...
FACTS:

1. According to the Pharmaceutical Companies themselves, these vaccines may not prevent
the SARS-COV-2 virus: Evidence:


a. From the Moderna and Pfizer Vaccine Fact Sheets: The (Moderna/Pfizer) COVID-19
Vaccine is a vaccine and may prevent you from getting COVID-19. There are no FDA
approved vaccines to prevent COVID-19.


b. However, the handout you get when they give you the shot, says it "...has been
authorized to prevent COVID-19", so they are lying about it.
They are experimental and have been approved by FDA and CDC via an Emergency Use Authorization (EUA) but
have not been fully tested.

...
2. These vaccines are experimental compounds that use "synthetic messenger RNA (mRNA)"
housed in fat cells. In 2005 an animal study was done with SARS-CoV-1 mRNA vaccines on
ferrets.
Two doses were administered in the same manner as the SARS-CoV-2, aka, COVID-19 mRNA Vaccines. The ferrets showed no adverse reaction and seemed to be completely healthy.

After some time, the ferrets were exposed to the SARS-CoV-1 coronavirus in the
wild. The ferrets died. The mRNA Vaccine had caused a cytokine storm, a fatal cascade of exaggerated immune responses. The SARS-CoV-1 vaccines was not further developed.


| - - - -

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251237/
Increased incidence of first‐trimester miscarriage during the COVID‐19 pandemic
K. G. Sacinti,corresponding author 1 E. Kalafat, 2 , 3 Y. E. Sukur, 1 and A. Koc 1
Ultrasound Obstet Gynecol. 2021 Jun; 57(6): 1013–1014.

There is limited research on the first‐trimester outcomes of women with coronavirus disease 2019 (COVID‐19). Recent meta‐analyses demonstrated the detrimental effect of COVID‐19 on preterm birth, Cesarean section rates and maternal morbidity 1 , 2 . However, the effect of first‐trimester severe acute respiratory syndrome coronavirus 2 (SA
RS‐CoV‐2) infection on early pregnancy outcome is still unknown.

| - - -

vaccine propaganda ?

many articles saying no link to vaccine and fertility ... millions to take it and lets wait and see ... hmmm


https://coronavirus.utah.gov/are-covid-19-vaccines-linked-to-infertility-or-miscarriage/
Are COVID-19 vaccines linked to infertility or miscarriage?
August 4, 2021

Are COVID-19 vaccines linked to infertility or miscarriage?

NO. While it's true that pregnant women were not enrolled in the original clinical trials, thousands of women have received the vaccine while they were pregnant or have become pregnant after getting the vaccine. Data shows that COVID-19 vaccines have not caused infertility, miscarriage, or complications with pregnancy or delivery for either the mother or baby.
 
However, many pregnant women who have gotten the COVID-19 virus during pregnancy have had serious complications caused by the virus. Pregnant women are at an increased risk for severe illness from COVID-19 because their immune response is not as high. A few studies and reputable sources on this can be found here, here, here, and here.

tahoeblue

https://miningawareness.wordpress.com/2021/08/25/fda-only-renewed-emergency-use-authorization-for-pfizer-approval-was-for-biontechs-comirnaty-with-years-of-additional-safety-studies-required-thru-2027/
FDA Only Renewed Emergency Use Authorization for Pfizer;
Approval was for BioNTech's Comirnaty with Years of Additional Safety Studies Required (Thru 2027)

Pfizer was not approved-licensed by the FDA, apart from Emergency Use Authorization. Rather, the European BioNTech mRNA vaccine, which is "legally distinct with certain differences" from Pfizer vaccine, was approved, but with conditions. There are many studies that the FDA is requiring them to complete, which won't be finished until 2027. In the interim, we predict that these products will be removed from the market. This Emergency Use Authorization apparently protects Pfizer from liability. However, from our understanding, vaccine mandates for military, etc., cannot be undertaken for non-licensed vaccines.

Currently, Comirnaty is not available in the United States. The manufacturing location is hidden in the approval. Why? Maybe it is made in Pfizer China? In the letter to BioNTech, it says: "Under this license, you are approved to manufacture COVID-19 Vaccine, mRNA drug substance at (b) (4) The final formulated product will be manufactured, filled, labeled and packaged at Pfizer (b) (4). The diluent, 0.9% Sodium Chloride Injection, USP, will be manufactured at (b) (4)"

The letter to BioNTech is literally signed Mary Malarkey! Didn't Biden say No Malarkey?

...

12. Study C4591012, entitled "Post-emergency Use Authorization Active Safety Surveillance Study Among Individuals in the Veteran's Affairs Health System Receiving Pfizer-BioNTech Coronavirus Disease 2019 (COVID-19) Vaccine."

Final Protocol Submission: January 29, 2021

Study Completion: June 30, 2023

Final Report Submission: December 31, 2023

...



Tags

Biologics license, BioNtech, BLA, Comirnaty, Covid 19 vaccine, Emergency Use Authorization, EUA, FDA, mRNA, mRNA vaccine, myocarditis, pediatrics, pericarditis, Pfizer, Pfizer-BioNTech, pregnancy, SARS-CoV-2, Vaccine approval, vaccine licensing

Pfizer was not approved-licensed by the FDA, apart from Emergency Use Authorization. Rather, the European BioNTech mRNA vaccine, which is "legally distinct with certain differences" from Pfizer vaccine, was approved, but with conditions. There are many studies that the FDA is requiring them to complete, which won't be finished until 2027. In the interim, we predict that these products will be removed from the market. This Emergency Use Authorization apparently protects Pfizer from liability. However, from our understanding, vaccine mandates for military, etc., cannot be undertaken for non-licensed vaccines. Currently, Comirnaty is not available in the United States. The manufacturing location is hidden in the approval. Why? Maybe it is made in Pfizer China? In the letter to BioNTech, it says: "Under this license, you are approved to manufacture COVID-19 Vaccine, mRNA drug substance at (b) (4) The final formulated product will be manufactured, filled, labeled and packaged at Pfizer (b) (4). The diluent, 0.9% Sodium Chloride Injection, USP, will be manufactured at (b) (4)"

The letter to BioNTech is literally signed Mary Malarkey! Didn't Biden say No Malarkey?

Excerpt from letter to Pfizer: "On August 23, 2021, FDA approved the biologics license application (BLA) submitted by BioNTech Manufacturing GmbH for COMIRNATY (COVID-19 Vaccine, mRNA) for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals 16 years of age and older.

On August 23, 2021, having concluded that revising this EUA is appropriate to protect the public health or safety under section 564(g)(2) of the Act, FDA is reissuing the August 12, 2021 letter of authorization in its entirety with revisions incorporated to clarify that the EUA will remain in place for the Pfizer-BioNTech COVID-19 vaccine for the previously-authorized indication and uses, and to authorize use of COMIRNATY (COVID-19 Vaccine, mRNA) under this EUA for certain uses that are not included in the approved BLA. In addition, the Fact Sheet for Healthcare Providers Administering Vaccine (Vaccination Providers) was revised to provide updates on expiration dating of the authorized Pfizer-BioNTech COVID-19 Vaccine and to update language regarding warnings and precautions related to myocarditis and pericarditis. The Fact Sheet for Recipients and Caregivers was updated as the Vaccine Information Fact Sheet for Recipients and Caregivers, which comprises the Fact Sheet for the authorized Pfizer-BioNTech COVID-19 Vaccine and information about the FDA-licensed vaccine, COMIRNATY (COVID-19 Vaccine, mRNA).

Pfizer-BioNTech COVID‑19 Vaccine contains a nucleoside-modified messenger RNA (modRNA) encoding the viral spike (S) glycoprotein of SARS-CoV-2 formulated in lipid particles. COMIRNATY (COVID-19 Vaccine, mRNA) is the same formulation as the Pfizer-BioNTech COVID-19 Vaccine and can be used interchangeably with the Pfizer-BioNTech COVID-19 Vaccine to provide the COVID-19 vaccination series.8
[8] The licensed vaccine has the same formulation as the EUA-authorized vaccine and the products can be used interchangeably to provide the vaccination series without presenting any safety or effectiveness concerns. The products are legally distinct with certain differences that do not impact safety or effectiveness...." Letter to Pfizer: https://www.fda.gov/media/150386/download

They were only studied for an average of 2 months after the second vaccine dose (median=half above and half below). This was apparently only for the original variant.

"C. There is no adequate, approved, and available9 alternative to the emergency use of Pfizer-BioNTech COVID‑19 Vaccine to prevent COVID-1 [9][10 ]

9 Although COMIRNATY (COVID-19 Vaccine, mRNA) is approved to prevent COVID-19 in individuals 16 years of age and older, there is not sufficient approved vaccine available for distribution to this population in its entirety at the time of reissuance of this EUA. Additionally, there are no products that are approved to prevent COVID-19 in individuals age 12 through 15, or that are approved to provide an additional dose to the immunocompromised population described in this EUA....

The Pfizer-BioNTech COVID‑19 Vaccine covered by this authorization will be administered by vaccination providers 13 and used only to prevent COVID-19 in individuals ages 12 and older; and • Pfizer-BioNTech COVID‑19 Vaccine may be administered by a vaccination provider without an individual prescription for each vaccine recipient.

This authorization also covers the use of the licensed COMIRNATY (COVID-19 Vaccine, mRNA) product when used to provide a two-dose regimen for individuals aged 12 through 15 years, or to provide a third dose to individuals 12 years of age or older who have undergone solid organ transplantation or who are diagnosed with conditions that are considered to have an equivalent level of immunocompromise...

Pfizer Inc. will conduct post-authorization observational studies to evaluate the association between Pfizer-BioNTech COVID-19 Vaccine and a pre-specified list of adverse events of special interest, along with deaths and hospitalizations, and severe COVID-19. The study population should include individuals administered the authorized Pfizer-BioNTech COVID-19 Vaccine under this EUA in the general U.S. population (12 years of age and older), populations of interest such as healthcare workers, pregnant women, immunocompromised individuals, subpopulations with specific comorbidities. The studies should be conducted in large scale databases with an active comparator. Pfizer Inc. will provide protocols and status update reports to the IND 19736 with agreed-upon study designs and milestone dates...

Z. If the Pfizer-BioNTech COVID‑19 Vaccine is exported from the United States, conditions C, D, and O through Y do not apply, but export is permitted only if 1) the regulatory authorities of the country in which the vaccine will be used are fully informed that this vaccine is subject to an EUA and is not approved or licensed by FDA and 2) the intended use of the vaccine will comply in all respects with the laws of the country in which the product will be used. The requirement in this letter that the authorized labeling (i.e., Fact Sheets) be made available to vaccination providers, recipients, and caregivers in condition A will not apply if the authorized labeling (i.e., Fact Sheets) are made available to the regulatory authorities of the country in which the vaccine will be used.

Conditions With Respect to Use of Licensed Product

AA. COMIRNATY (COVID-19 Vaccine, mRNA) is now licensed for individuals 16 years of age and older. There remains, however, a significant amount of Pfizer-BioNTech COVID-19 vaccine that was manufactured and labeled in accordance with this emergency use authorization. This authorization thus remains in place with respect to that product for the previously-authorized indication and uses (i.e., for use to prevent COVID-19 in individuals 12 years of age and older with a two-dose regimen, and to provide a third dose to individuals 12 years of age or older who have undergone solid organ transplantation, or who are diagnosed with conditions that are considered to have an equivalent level of immunocompromise).

BB. This authorization also covers the use of the licensed COMIRNATY (COVID-19 Vaccine, mRNA) product when used to provide a two-dose regimen for individuals aged 12 through 15 years, or to provide a third dose to individuals 12 years of age or older who have undergone solid organ transplantation or who are diagnosed with conditions that are considered to have an equivalent level of immunocompromise. Conditions A through W in this letter apply when COMIRNATY (COVID-19 Vaccine, mRNA) is provided for the uses described in this subsection III.BB, except that product manufactured and labeled in accordance with the approved BLA is deemed to satisfy the manufacturing, labeling, and distribution requirements of this authorization.

IV. Duration of Authorization

This EUA will be effective until the declaration that circumstances exist justifying the authorization of the emergency use of drugs and biological products during the COVID-19 pandemic is terminated under Section 564(b)(2) of the Act or the EUA is revoked under Section 564(g) of the Act.

Sincerely,

–/S/–

____________________________ RADM Denise M. Hinton Chief Scientist Food and Drug Administration" Letter to Pfizer: https://www.fda.gov/media/150386/download

In the letter to BioNTech: "You may label your product with the proprietary name, COMIRNATY, and market it in 2.0 mL glass vials, in packages of 25 and 195 vials. We did not refer your application to the Vaccines and Related Biological Products Advisory Committee because our review of information submitted in your BLA, including the clinical study design and trial results, did not raise concerns or controversial issues that would have benefited from an advisory committee discussion."

YET FOR BIONTECH-Comirnaty, SAFETY STUDIES STILL REQUIRED UNTIL 2027:
Pediatric studies final report due October 31, 2024 (see list of studies below);
Study C4591009, entitled "A Non-Interventional Post-Approval Safety Study of the Pfizer-BioNTech COVID-19 mRNA Vaccine in the United States," to evaluate the occurrence of myocarditis and pericarditis following administration of COMIRNATY, Final report October 31, 2025".
"Study C4591021, entitled "Post Conditional Approval Active Surveillance Study Among Individuals in Europe Receiving the Pfizer-BioNTech Coronavirus Disease 2019 (COVID-19) Vaccine," to evaluate the occurrence of myocarditis and pericarditis following administration of COMIRNATY. Final Report Submission: September 30, 2024";
"Study C4591036, a prospective cohort study with at least 5 years of follow-up for potential long-term sequelae of myocarditis after vaccination (in collaboration with Pediatric Heart Network). Final Report Submission: May 31, 2027."
"Study C4591007 substudy to prospectively assess the incidence of subclinical myocarditis following administration of the second dose of COMIRNATY in a subset of participants 5 through 15 years of age. Final Report Submission: May 31, 2024 "
"Study C4591031 substudy to prospectively assess the incidence of subclinical myocarditis following administration of a third dose of COMIRNATY in a subset of participants 16 to 30 years of age. Final Report Submission: December 31, 2022 https://www.fda.gov/media/151710/download

WHY ARE THEY HIDING THE MANUFACTURING LOCATIONS? BECAUSE THEY WILL BE MADE IN CHINA?

The letter, below, is literally signed Mary Malarkey! Didn't Biden say No Malarkey?

"Our STN: BL 125742/0 BLA APPROVAL

BioNTech Manufacturing GmbH August 23, 2021 Attention: Amit Patel Pfizer Inc. 235 East 42nd Street New York, NY 10017

Dear Mr. Patel:

Please refer to your Biologics License Application (BLA) submitted and received on May 18, 2021, under section 351(a) of the Public Health Service Act (PHS Act) for COVID-19 Vaccine, mRNA.

LICENSING

U.S. Food & Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 w ww.fda.gov

We are issuing Department of Health and Human Services U.S. License No. 2229 to BioNTech Manufacturing GmbH, Mainz, Germany, under the provisions of section 351(a) of the PHS Act controlling the manufacture and sale of biological products. The license authorizes you to introduce or deliver for introduction into interstate commerce, those products for which your company has demonstrated compliance with establishment and product standards.

Under this license, you are authorized to manufacture the product, COVID-19 Vaccine, mRNA, which is indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 16 years of age and older.

The review of this product was associated with the following National Clinical Trial (NCT) numbers: NCT04368728 and NCT04380701.

MANUFACTURING LOCATIONS

Under this license, you are approved to manufacture COVID-19 Vaccine, mRNA drug substance at (b) (4) The final formulated product will be manufactured, filled, labeled and packaged at Pfizer (b) (4). The diluent, 0.9% Sodium Chloride Injection, USP, will be manufactured at (b) (4)

Page 2 – STN BL 125742/0 – Elisa Harkins

You may label your product with the proprietary name, COMIRNATY, and market it in 2.0 mL glass vials, in packages of 25 and 195 vials. We did not refer your application to the Vaccines and Related Biological Products Advisory Committee because our review of information submitted in your BLA, including the clinical study design and trial results, did not raise concerns or controversial issues that would have benefited from an advisory committee discussion...

PEDIATRIC REQUIREMENTS

Under the Pediatric Research Equity Act (PREA) (21 U.S.C. 355c), all applications for new active ingredients, new indications, new dosage forms, new dosing regimens, or new routes of administration are required to contain an assessment of the safety and effectiveness of the product for the claimed indication in pediatric patients unless this requirement is waived, deferred, or inapplicable.

We are deferring submission of your pediatric studies for ages younger than 16 years for this application because this product is ready for approval for use in individuals 16 years of age and older, and the pediatric studies for younger ages have not been completed.

Page 5 – STN BL 125742/0 – Elisa Harkins

Your deferred pediatric studies required under section 505B(a) of the Federal Food, Drug, and Cosmetic Act (FDCA) are required postmarketing studies. The status of these postmarketing studies must be reported according to 21 CFR 601.28 and section 505B(a)(4)(C) of the FDCA. In addition, section 506B of the FDCA and 21 CFR 601.70 require you to report annually on the status of any postmarketing commitments or required studies or clinical trials.

Label your annual report as an "Annual Status Report of Postmarketing Study Requirement/Commitments" and submit it to the FDA each year within 60 calendar days of the anniversary date of this letter until all Requirements and Commitments subject to the reporting requirements under section 506B of the FDCA are released or fulfilled. These required studies are listed below:

1. Deferred pediatric Study C4591001 to evaluate the safety and effectiveness of COMIRNATY in children 12 years through 15 years of age.

Final Protocol Submission: October 7, 2020

Study Completion: May 31, 2023

Final Report Submission: October 31, 2023

2. Deferred pediatric Study C4591007 to evaluate the safety and effectiveness of COMIRNATY in infants and children 6 months to <12 years of age.

Final Protocol Submission: February 8, 2021

Study Completion: November 30, 2023

Final Report Submission: May 31, 2024

3. Deferred pediatric Study C4591023 to evaluate the safety and effectiveness of COMIRNATY in infants <6 months of age.

Final Protocol Submission: January 31, 2022

Study Completion: July 31, 2024

Final Report Submission: October 31, 2024

Submit the protocols to your IND 19736, with a cross-reference letter to this BLA STN BL 125742 explaining that these protocols were submitted to the IND. Please refer to the PMR sequential number for each study/clinical trial and the submission number as shown in this letter. Submit final study reports to this BLA STN BL 125742. In order for your PREA PMRs to be considered fulfilled, you must submit and receive approval of an efficacy or a labeling

Page 6 – STN BL 125742/0 – Elisa Harkins

supplement. For administrative purposes, all submissions related to these required pediatric postmarketing studies must be clearly designated as:

• Required Pediatric Assessment(s)

We note that you have fulfilled the pediatric study requirement for ages 16 through 17 years for this application.

POSTMARKETING REQUIREMENTS UNDER SECTION 505(o)

Section 505(o) of the Federal Food, Drug, and Cosmetic Act (FDCA) authorizes FDA to require holders of approved drug and biological product applications to conduct postmarketing studies and clinical trials for certain purposes, if FDA makes certain findings required by the statute (section 505(o)(3)(A), 21 U.S.C. 355(o)(3)(A)).

We have determined that an analysis of spontaneous postmarketing adverse events reported under section 505(k)(1) of the FDCA will not be sufficient to assess known serious risks of myocarditis and pericarditis and identify an unexpected serious risk of subclinical myocarditis.

Furthermore, the pharmacovigilance system that FDA is required to maintain under section 505(k)(3) of the FDCA is not sufficient to assess these serious risks.

Therefore, based on appropriate scientific data, we have determined that you are required to conduct the following studies:

4. Study C4591009, entitled "A Non-Interventional Post-Approval Safety Study of the Pfizer-BioNTech COVID-19 mRNA Vaccine in the United States," to evaluate the occurrence of myocarditis and pericarditis following administration of COMIRNATY.

We acknowledge the timetable you submitted on August 21, 2021, which states that you will conduct this study according to the following schedule:

Final Protocol Submission: August 31, 2021

Monitoring Report Submission: October 31, 2022

Interim Report Submission: October 31, 2023

Study Completion: June 30, 2025

Final Report Submission: October 31, 2025

5. Study C4591021, entitled "Post Conditional Approval Active Surveillance Study Among Individuals in Europe Receiving the Pfizer-BioNTech Coronavirus

Page 7 – STN BL 125742/0 – Elisa Harkins

Disease 2019 (COVID-19) Vaccine," to evaluate the occurrence of myocarditis and pericarditis following administration of COMIRNATY.

We acknowledge the timetable you submitted on August 21, 2021, which states that you will conduct this study according to the following schedule:

Final Protocol Submission: August 11, 2021

Progress Report Submission: September 30, 2021

Interim Report 1 Submission: March 31, 2022

Interim Report 2 Submission: September 30, 2022

Interim Report 3 Submission: March 31, 2023

Interim Report 4 Submission: September 30, 2023

Interim Report 5 Submission: March 31, 2024

Study Completion: March 31, 2024

Final Report Submission: September 30, 2024

6. Study C4591021 substudy to describe the natural history of myocarditis and pericarditis following administration of COMIRNATY.

We acknowledge the timetable you submitted on August 21, 2021, which states that you will conduct this study according to the following schedule:

Final Protocol Submission: January 31, 2022

Study Completion: March 31, 2024

Final Report Submission: September 30, 2024

7. Study C4591036, a prospective cohort study with at least 5 years of follow-up for potential long-term sequelae of myocarditis after vaccination (in collaboration with Pediatric Heart Network).


We acknowledge the timetable you submitted on August 21, 2021, which states that you will conduct this study according to the following schedule:

Final Protocol Submission: November 30, 2021

Study Completion: December 31, 2026

Page 8 – STN BL 125742/0 – Elisa Harkins

Final Report Submission: May 31, 2027

tahoeblue

With all the bad press on Ivermectin ... the WONDER DRUG ...
what does the NIH have to say ?


https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3043740/
Ivermectin, 'Wonder drug' from Japan: the human use perspective
Andy CRUMP*1 and Satoshi ŌMURA*1†
Editor: Satoshi ŌMURA

Proc Jpn Acad Ser B Phys Biol Sci. 2011 Feb 10; 87(2): 13–28.
doi: 10.2183/pjab.87.13
...

Ivermectin proved to be even more of a 'Wonder drug' in human health, improving the nutrition, general health and wellbeing of billions of people worldwide ever since it was first used to treat Onchocerciasis in humans in 1988. It proved ideal in many ways, being highly effective and broad-spectrum, safe, well tolerated and could be easily administered (a single, annual oral dose). It is used to treat a variety of internal nematode infections, including Onchocerciasis, Strongyloidiasis, Ascariasis, cutaneous larva migrans, filariases, Gnathostomiasis and Trichuriasis, as well as for oral treatment of ectoparasitic infections, such as Pediculosis (lice infestation) and scabies (mite infestation).14)

Ivermectin is the essential mainstay of two global disease elimination campaigns that should soon rid the world of two of its most disfiguring and devastating diseases, Onchocerciasis and Lymphatic filariasis, which blight the lives of billions of the poor and disadvantaged throughout the tropics.

It is likely that, throughout the next decade, well over 200 million people will be taking the drug annually or semi-annually, via innovative globally-coordinated Mass Drug Administration (MDA) programmes. Indeed, the discovery, development and deployment of ivermectin, produced by an unprecedented partnership between the Private Sector pharmaceutical multinational Merck & Co. Inc., and the Public Sector Kitasato Institute in Tokyo, aided by an extraordinary coalition of multidisciplinary international partners and disease-affected communities, has been recognized by many experts and observers as one of the greatest medical accomplishments of the 20th century.15)

In referring to the international efforts to tackle Onchocerciasis in which ivermectin is now the sole control tool, the UNESCO World Science Report concluded, "the progress that has been made in combating the disease represents one of the most triumphant public health campaigns ever waged in the developing world".16)

| - - -

https://rclutz.com/2021/08/19/greenlight-for-ivermectin-in-japan/
Greenlight for Ivermectin in Japan
Posted on 8 Days Ago by Ron Clutz

Article at gnews reports on announcement by Dr. Ozaki, chairman of the Tokyo Metropolitan Medical Association Greenlight for Ivermectin in Japan.  Excerpts in italics with my bolds.

Since Tokyo summer Olympic Game ended on August 8, 2021, the urgent status of the pandemic as Japan is now in its worst surge of the COVID-19 pandemic since the onset of the crisis in such a megacity of 14 million. Most recently, a record number of new cases were reported at 20,140 on August 14. Deaths aren't as high as successive waves of the pandemic from February 2021 to the end of May, but nerves are frayed with record numbers of infections.

Dr. Ozaki, The chairman of the Tokyo Metropolitan Medical Association, recently led an emergency press conference on August 13, Dr. Haruo Ozaki shared those 18,000 new infections are reported daily. However, the death count has eased as compared to previous surges.

How to deal with the current dilemma is a huge challenge to Japanese government and medical agencies?

Fortunately, India has an excellent testimonial. Since April 28, India medical officials started providing Hydroxychloroquine and ivermectin to its massive population.

As India is the major pharmaceutical manufacture in the world, they were ready for this massive drug distribution. Miraculously, COVID cases have plummeted quickly since then thanks to the new rules.

Dr. Ozaki declared that ivermectin has demonstrated significant benefits in reducing infections and deaths where the regimen is prophylactically administered for another indication. With the encouraging medical data from ivermectin clinical trials' reports worldwide, especially the one from FLCCC of US and BIRD of UK, the head of the Metropolitan Medical Association declared that while clinical trials were important, it was time to greenlight doctors to prescribe ivermectin in association with giving the patient informed consent.

| = = = =

Are People are self medicating ? Badly ? careful ...
When you cant get a doctor ...
Who are these people OD'ing on Ivermectin ?

These are prescriptions - So who's the Doctor ? eh ?

So the problems are with the people self prescribing with bad medicine or wrong dosage
because they don't have a doctor that will do it for them !!! ...



CNN >?

https://www.cnn.com/2021/08/26/health/ivermectin-covid-19-warning-injuries/index.html

CDC warns against use of anti-parasitic drug ivermectin for Covid-19, as calls to poison control centers increase
August 26, 2021
By Jen Christensen, CNN

(CNN)The US Centers for Disease Control and Prevention sent a health advisory Thursday warning doctors and the public about the "rapid increase" in prescriptions for the anti-parasitic drug ivermectin.


The CDC also cautions about an increase in reports of severe illness caused by the drug to poison centers.
...
Normally, about 3,600 prescriptions are written for ivermectin in a week, the CDC said. This rose more than tenfold by the week of January 8, when 39,000 prescriptions were written. "Since early July 2021, outpatient ivermectin dispensing has again begun to rapidly increase, reaching more than 88,000 prescriptions in the week ending August 13, 2021. This represents a 24-fold increase from the pre-pandemic baseline," the CDC said.
...

Some examples of these calls included an adult who wanted to prevent Covid-19 and had to be hospitalized for nine days after drinking a cattle formula. Another person who bought pills online to treat their Covid-19 infection was hospitalized after taking five tablets a day for five days.
...
Overdoses of the drug can cause stomach problems, nerve damage, seizures, disorientation, coma and death.

tahoeblue

Interesting audio ...  when Spanish Flu gene was resurrected and put into Italian 2019 flu vaccine

http://mediaarchives.gsradio.net/rense/special/rense_043021_hr3.mp3
Jeff And Dr. Judy Mikovits - How We Got Here - And What To Do


Dr. Naomi Hunter

https://twitter.com/Xbox/status/1431340820079075332

https://twitter.com/BristolBlues32/status/1431838118035042305?ref_src=twsrc%5Etfw


Dr. Naomi Hunter


tahoeblue

https://www.bitchute.com/video/1338kLyYzeAp/
First published at 01:17 UTC on July 15th, 2021.
 
Leading German lawyer and member of the German Corona Investigative Committee, Dr. Reiner Fuellmich specialises globally on the prosecution of fraudulent corporations.

 He now leads a team of international lawyers in what will become the world's largest global tort case—against all protagonists and accomplices in what is now being called, "The COVID Scandal."

The team of more than 1,000 lawyers and over 10,000 medical experts has initiated legal proceedings against the CDC, WHO and the Davos Group for crimes against humanity
. Dr. Fuellmich is currently preparing the largest class action lawsuit in history, a kind of "Nuremberg 2.0".

Transcript testimony Reiner Fuellmich
https://www.aeginagreece.com/aegina-island/wp-content/uploads/2020/12/Transcript-testimony-Reiner-Fuellmich-.pdf

Also see:

Reiner Fuellmich (June 9, 2021) Interview - Worldwide Legal cases & what's coming this Fall & Winter
https://www.bitchute.com/video/1DKzs0Pg3ubh/

Video excerpt from:
https://www.bitchute.com/video/XwEu0vHf8DWf/

| - - - -



https://ratical.org/PandemicParallaxView/CC-SARS-Cov2andLC-14Sep2020.pdf
Corona Foundation Committee
Report (short) SARS-CoV2 and the Lockdown Consequences
Berlin -14 September 2020

CORONA COMMITTEE REPORT (BRIEF)
 
Introduction
The  Corona  Committee  was  set  up  in  July  2020  by  attorneys  Antonia  Fischer  and Viviane Fischer and lawyers Dr. Reiner Fullmich and Dr. Justus Hoffmann. It seeks answers to the  legal  questions  of  whether  the  anti-Corona  measures  taken  by  the  federal  and  state governments  against  a  possible  overloading  of  the  healthcare  system  ("flattening  the  curve") and to prevent SARS-CoV2 deaths were suitable, necessary and proportionate - in accordance with the constitutional standard of review - or whether the collateral damage that occurred was culpably caused. To this end, experts and witnesses were questioned on the matter in a total of 13 sessions between July 14, 2020 and August 21, 2020. This short report provides an overview of  the  most  significant  findings  of  the  meetings. 

...
CORONA COMMITTEE REPORT (BRIEF)
 
Dangerousness of the virus
It  quickly  became  clear  that  fears  that  SARS-CoV-2  would  be  significantly  more dangerous than influenza in terms of transmissibility, disease burden, and mortality proved to be unfounded.

...

Donald  Trump's  hospital  ship  had  been  virtually  empty.  In  addition,  while  the  spectacular treatments  allegedly  took  place  in  atypical  locations,  completely  intact  hospitals  were  closed.

Incidentally, no differences had been found between the number of people testing positive in the states with and without lockdown.

...

Preliminary result

Based on the current state of knowledge, there is a great deal to suggest that the risk posed by SARS- CoV-2 was greatly overestimated, but that the risks and damage caused by the  measures  were  not  sufficiently  taken  into  account.

The  government  already  stated  in April  2020  that  it  had  not  conducted  an  impact  assessment  and  did  not  plan  to  do  so.  In proceedings  before  the  Bavarian  Administrative  Court  led  by  lawyer  Jessica  Hamed,  the Bavarian State Chancellery let it be known that to date - in violation of the principle of the rule  of  law,  according  to  which  all  government  action  must  be  verifiable  - there  are  no documents,  no  written  expert  reports  on  the  impact  assessment.  This  is  to  be  regarded  as grossly  negligent at  the  very  least,  especially  in  view  of  the  ever-increasing  reports  of lockdown damage to businesses, children, the elderly, etc.

tahoeblue

bottom line - there can be no mainline therapies for covid ... EVER ,,,
or else people wont take the SHOT (emer fda approval revocation ? ) ...


https://www.zerohedge.com/covid-19/rolling-stone-horse-dewormer-hit-piece-debunked-after-hospital-says-no-ivermectin
Rolling Stone Issues 'Update' After Horse Dewormer Hit-Piece Debunked

After Joe Rogan announced that he'd kicked Covid in just a few days using a cocktail of drugs, including Ivermectin - an anti-parasitic prescribed for humans for over 35 years, with over 4 billion doses administered (and most recently as a Covid-19 treatment), the left quickly started mocking Rogan for having taken a 'horse dewormer' due to its dual use in livestock.




tahoeblue

https://covid19criticalcare.com/guide-for-this-website/how-to-get-ivermectin/
How to Get Ivermectin

We understand and empathize with the challenges faced in obtaining a prescription for ivermectin during this time period prior to its use being formally adopted in national or international COVID-19 treatment guidelines. However, we are anticipating these treatment guidelines to be updated in the near future.

Alternately, please know our scientific review manuscript on ivermectin in COVID-19 is undergoing expedited peer-review at a prominent American medical journal, and if it passes peer review and becomes published, we anticipate that this will also make access to ivermectin more widespread.

 However, until such a time when its use as both a preventive and treatment agent is more widely accepted or recommended, many physicians will be reluctant to prescribe. We can only suggest the following approaches:

We can only suggest the following approaches:

    Discuss with your primary health care provider. If they are unconvinced of the data, share with them our manuscript which can be downloaded  from the FLCCC Alliance Website. Please understand that many will prefer to avoid adoption of ivermectin treatment until such a time as the guidelines are updated or the manuscript gets published.
    The second option is to try one of the doctors that can provide telemedicine consultation here: Directory of Doctors Prescribing Ivermectin (international), or from the table below (US only) — Confirm the price of any visit prior to the consultation. We have reports of some doctors charging exorbitant fees.

If your doctor will not prescribe ivermectin for you, please contact one of the following tele-health companies (US only):

IMPORTANT NOTICE AND DISCLAIMER: This list of doctors and medical providers is ONLY a collection of information offered as a convenience to interested members of the public and is neither a recommendation of the provider nor a verification of the provider's qualifications or practices, medical or otherwise. FLCCC has not undertaken any investigation of the medical providers or the accuracy of the information provided herein. Accordingly, reliance on any such information provided herein is solely at your own risk. Your independent investigation and evaluation is therefore strongly advised. Neither the FLCCC, its physicians and principals nor any individual associated with FLCCC is responsible or liable for the use or misuse of the information provided herein, and your use thereof or of this website acknowledges and accepts these terms.

tahoeblue

https://www.breitbart.com/asia/2021/09/07/report-top-scientist-claims-anthony-fauci-untruthful-about-chinese-lab-research/

Fauci FOIA: $600k Grant to Wuhan Lab Helped 'identify & alter bat coronaviruses likely to infect humans'

Top Scientist Says Fauci, Francis Collins Were 'Untruthful'

The Intercept reported 900 new pages of previously undisclosed information from the NIH, which The Intercept obtained through a a Freedom of Information Act (FOIA) lawsuit, that the EcoHealth Alliance used federal grant money to fund dangerous bat coronavirus research in the Chinese labs. The Intercept reported:

QuoteThe bat coronavirus grant provided the EcoHealth Alliance with a total of $3.1 million, including $599,000 that the Wuhan Institute of Virology used in part to identify and alter bat coronaviruses likely to infect humans. Even before the pandemic, many scientists were concerned about the potential dangers associated with such experiments.

    The grant proposal acknowledges some of those dangers: "Fieldwork involves the highest risk of exposure to SARS or other CoVs, while working in caves with high bat density overhead and the potential for fecal dust to be inhaled."

Richard Ebright, a molecular biologist at Rutgers University, reviewed the material and told The Intercept the "viruses they constructed were tested for their ability to infect [GMO humanized (my addition because that how they roll) ] mice that were engineered to display human type receptors on their cell."

...

Ebright concluded by accusing Fauci and NIH Director, Francis Collins, of being "untruthful" in their previous remarks on the matter.
"The documents make it clear that assertions by the NIH Director, Francis Collins, and the NIAID Director, Anthony Fauci, that the NIH did not support gain-of-function research or potential pandemic pathogen enhancement at WIV are untruthful," he wrote.

tahoeblue

https://blog.nomorefakenews.com/2021/09/07/the-quack-theory-of-vaccination-idiots-delight/
The Quack Theory of Vaccination; idiot's delight
by Jon Rappoport   



"Do I need a vaccination to prepare me for a vaccination?"
by Jon Rappoport
September 7, 2021

...
In 1987, while writing my first book, AIDS INC., I had a long conversation with Richard about vaccination. It was my first trip exploring vaccines as a form of immune-system suppression.

I came away from the conversation with an idea about how vaccines could be touted and trumpeted as the reason for vastly reducing cases of diseases, when in fact the reduction of visible symptoms was occurring—a very different thing.

If vaccines were lowering immune-system response, then the acute, vigorous, and all-out inflammatory reaction to germs would be eliminated. And it IS that acute reaction which creates the visible symptoms (rashes, spots, etc.).

After vaccination, "Voila, no measles," the experts say. But really, as a result of vaccination, it's just the visible rash that is missing, while something more dangerous, out of view, is going on in the body.

I'm printing here an excerpt from Richard's article (written years ago), The Case Against Immunizations. The article is based on a classical view of germs and the action of the human immune system. The pros and cons of germ theory itself are a different matter, about which I've spoken and written in other places.

tahoeblue

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072585/
Published online 2021 Apr 18. doi: 10.3390/v13040700
PMCID: PMC8072585
PMID: 33919537
Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms


Abstract

The COVID-19 pandemic has infected millions worldwide, leaving a global burden for long-term care of COVID-19 survivors.

It is thus imperative to study post-COVID (i.e., short-term) and long-COVID (i.e., long-term) effects, specifically as local and systemic pathophysiological outcomes of other coronavirus-related diseases (such as Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS)) were well-cataloged.

We conducted a comprehensive review of adverse post-COVID health outcomes and potential long-COVID effects.

We observed that such adverse outcomes were not localized. Rather, they affected different human systems, including:
(i) immune system (e.g., Guillain–Barré syndrome, rheumatoid arthritis, pediatric inflammatory multisystem syndromes such as Kawasaki disease),
(ii) hematological system (vascular hemostasis, blood coagulation),
(iii) pulmonary system (respiratory failure, pulmonary thromboembolism, pulmonary embolism, pneumonia, pulmonary vascular damage, pulmonary fibrosis),
(iv) cardiovascular system (myocardial hypertrophy, coronary artery atherosclerosis, focal myocardial fibrosis, acute myocardial infarction, cardiac hypertrophy),
(v) gastrointestinal, hepatic, and renal systems (diarrhea, nausea/vomiting, abdominal pain, anorexia, acid reflux, gastrointestinal hemorrhage, lack of appetite/constipation),
(vi) skeletomuscular system (immune-mediated skin diseases, psoriasis, lupus),
(vii) nervous system (loss of taste/smell/hearing, headaches, spasms, convulsions, confusion, visual impairment, nerve pain, dizziness, impaired consciousness, nausea/vomiting, hemiplegia, ataxia, stroke, cerebral hemorrhage),
(viii) mental health (stress, depression and anxiety).

We additionally hypothesized mechanisms of action by investigating possible molecular mechanisms associated with these disease outcomes/symptoms. Overall, the COVID-19 pathology is still characterized by cytokine storm that results to endothelial inflammation, microvascular thrombosis, and multiple organ failures.

...


https://www.healio.com/news/rheumatology/20210514/missing-link-lingering-questions-at-the-intersection-of-covid19-and-autoimmunity
Missing link: Lingering questions at the intersection of COVID-19 and autoimmunity
May 20, 2021

...

"I think this is merely the beginning of our understanding of autoimmunity as a sequelae of COVID-19 infection, as well as the result of a new class of vaccines," Calabrese said. He expressed concerns that, with a vaccine now planned for billions of people around the world, "we should expect to see more rare and unusual complications of possible autoimmune origin."

...

The next question, for Calabrese, is whether the autoantibody production has association with post-COVID-19 syndromes in the so-called 'long haulers'. "This is the forefront of research right now, and there is definitely an interesting case to be made," he said.

An additional area of research worth investigating is what happens when people with autoimmune diseases acquire COVID-19. "It is still unclear whether they make new or different autoantibodies," Calabrese said, and added one more question for consideration. "What will happen to their autoimmune disease as they age, post-COVID-19?"

...

| - - - -

https://medlineplus.gov/ency/article/000573.htm

Disseminated intravascular coagulation (DIC)
Email this page to a friend Print Facebook Twitter Pinterest

Disseminated intravascular coagulation (DIC) is a serious disorder in which the proteins that control blood clotting become overactive.
Causes

When you are injured, proteins in the blood that form blood clots travel to the injury site to help stop bleeding. If these proteins become abnormally active throughout the body, you could develop DIC. The underlying cause is usually due to inflammation, infection, or cancer.

In some cases of DIC, small blood clots form in the blood vessels. Some of these clots can clog the vessels and cut off the normal blood supply to organs such as the liver, brain, or kidneys. Lack of blood flow can damage and cause major injury to the organs.

In other cases of DIC, the clotting proteins in your blood are consumed. When this happens, you may have a high risk of serious bleeding, even from a minor injury or without injury. You may also have bleeding that starts spontaneously (on its own). The disease can also cause your healthy red blood cells to fragment and break up when they travel through the small vessels that are filled with clots.

...

https://www.uptodate.com/contents/covid-19-hypercoagulability#!
COVID-19: Hypercoagulability
This topic last updated: Sep 03, 2021.

INTRODUCTIONA novel coronavirus was identified in late 2019 that rapidly reached pandemic proportions. The World Health Organization has designated the disease caused by the virus (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]) as coronavirus disease 2019 (COVID-19).

Individuals with COVID-19 may have a number of complex and varied coagulation abnormalities that create a hypercoagulable state, raising questions about appropriate evaluations and interventions to prevent or treat thrombosis.

This topic reviews evaluation and management of coagulation abnormalities in individuals with COVID-19.


PATHOGENESIS

The pathogenesis of hypercoagulability in COVID-19 is incompletely understood.

tahoeblue

What lying bastards ...  They all knew exactly what this was ... a GLOBAL BIOWEAPON

https://www.cnbc.com/2021/09/07/who-says-covid-is-here-to-stay-as-hopes-for-eradicating-the-virus-diminish.html
WHO says Covid will mutate like the flu and is likely here to stay
Published Tue, Sep 7 2021

"I think this virus is here to stay with us and it will evolve like influenza pandemic viruses, it will evolve to become one of the other viruses that affects us," Dr. Mike Ryan, executive director of the World Health Organization's Health Emergencies Program, said at a press briefing.
...
Dr. Anthony Fauci and Stephane Bancel, CEO of Covid vaccine maker Moderna, have warned that the world will have to live with Covid forever, much like influenza.

...
If the world had taken early steps to stop the spread of the virus, the situation today could have been very different, WHO officials said.

One Revelator

Shipp knows exactly who "they" are. Books and slideshow available.